Global Vaccine Vial Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Vaccine bottles are made of special glass, usually containing 2 ml to 100 ml of liquid, with an average height of 45 mm.In addition, vaccine bottles must also be resistant to low temperatures and be able to withstand the wear and tear caused by global transportation.
LPI (LP Information)' newest research report, the “Vaccine Vial Industry Forecast” looks at past sales and reviews total world Vaccine Vial sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Vial sales for 2023 through 2029. With Vaccine Vial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Vial industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Vial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Vial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccine Vial market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Vial and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Vial.
The global Vaccine Vial market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Vial players cover Schott, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd and Stevanato Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Vial market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Vaccine Vial market?
What factors are driving Vaccine Vial market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Vial market opportunities vary by end market size?
How does Vaccine Vial break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Vaccine bottles are made of special glass, usually containing 2 ml to 100 ml of liquid, with an average height of 45 mm.In addition, vaccine bottles must also be resistant to low temperatures and be able to withstand the wear and tear caused by global transportation.
LPI (LP Information)' newest research report, the “Vaccine Vial Industry Forecast” looks at past sales and reviews total world Vaccine Vial sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Vial sales for 2023 through 2029. With Vaccine Vial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Vial industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Vial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Vial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccine Vial market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Vial and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Vial.
The global Vaccine Vial market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Vial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Vial players cover Schott, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd and Stevanato Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Vial market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- by Capacity
- Single Dose
- Multi-dose
- by Product Type
- Molded Glass Vial
- Tubular Glass Vial
- Preventive Vaccine
- Therapeutic Vaccine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Schott
- Nippon Electric Glass
- Corning
- DWK Life Sciences
- Richland Glass
- Nipro
- Pacific Vial Manufacturing
- Origin Ltd
- Stevanato Group
- SGD Pharma
- Piramal Glass
- Zheng Chuan
- Shandong Pharmaceutical Glass
- Gerresheimer
- Four Stars Glass
- JOTOP Glass
What is the 10-year outlook for the global Vaccine Vial market?
What factors are driving Vaccine Vial market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Vial market opportunities vary by end market size?
How does Vaccine Vial break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Vial Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccine Vial by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccine Vial by Country/Region, 2018, 2022 & 2029
2.2 Vaccine Vial Segment by Type
2.2.1 Single Dose
2.2.2 Multi-dose
2.3 Vaccine Vial Sales by Type
2.3.1 Global Vaccine Vial Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccine Vial Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccine Vial Sale Price by Type (2018-2023)
2.4 Vaccine Vial Segment by Application
2.4.1 Preventive Vaccine
2.4.2 Therapeutic Vaccine
2.5 Vaccine Vial Sales by Application
2.5.1 Global Vaccine Vial Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccine Vial Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccine Vial Sale Price by Application (2018-2023)
3 GLOBAL VACCINE VIAL BY COMPANY
3.1 Global Vaccine Vial Breakdown Data by Company
3.1.1 Global Vaccine Vial Annual Sales by Company (2018-2023)
3.1.2 Global Vaccine Vial Sales Market Share by Company (2018-2023)
3.2 Global Vaccine Vial Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccine Vial Revenue by Company (2018-2023)
3.2.2 Global Vaccine Vial Revenue Market Share by Company (2018-2023)
3.3 Global Vaccine Vial Sale Price by Company
3.4 Key Manufacturers Vaccine Vial Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Vial Product Location Distribution
3.4.2 Players Vaccine Vial Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINE VIAL BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Vial Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccine Vial Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccine Vial Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccine Vial Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccine Vial Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccine Vial Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccine Vial Sales Growth
4.4 APAC Vaccine Vial Sales Growth
4.5 Europe Vaccine Vial Sales Growth
4.6 Middle East & Africa Vaccine Vial Sales Growth
5 AMERICAS
5.1 Americas Vaccine Vial Sales by Country
5.1.1 Americas Vaccine Vial Sales by Country (2018-2023)
5.1.2 Americas Vaccine Vial Revenue by Country (2018-2023)
5.2 Americas Vaccine Vial Sales by Type
5.3 Americas Vaccine Vial Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Vial Sales by Region
6.1.1 APAC Vaccine Vial Sales by Region (2018-2023)
6.1.2 APAC Vaccine Vial Revenue by Region (2018-2023)
6.2 APAC Vaccine Vial Sales by Type
6.3 APAC Vaccine Vial Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Vial by Country
7.1.1 Europe Vaccine Vial Sales by Country (2018-2023)
7.1.2 Europe Vaccine Vial Revenue by Country (2018-2023)
7.2 Europe Vaccine Vial Sales by Type
7.3 Europe Vaccine Vial Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Vial by Country
8.1.1 Middle East & Africa Vaccine Vial Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccine Vial Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccine Vial Sales by Type
8.3 Middle East & Africa Vaccine Vial Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Vial
10.3 Manufacturing Process Analysis of Vaccine Vial
10.4 Industry Chain Structure of Vaccine Vial
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Vial Distributors
11.3 Vaccine Vial Customer
12 WORLD FORECAST REVIEW FOR VACCINE VIAL BY GEOGRAPHIC REGION
12.1 Global Vaccine Vial Market Size Forecast by Region
12.1.1 Global Vaccine Vial Forecast by Region (2024-2029)
12.1.2 Global Vaccine Vial Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccine Vial Forecast by Type
12.7 Global Vaccine Vial Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Schott
13.1.1 Schott Company Information
13.1.2 Schott Vaccine Vial Product Portfolios and Specifications
13.1.3 Schott Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Schott Main Business Overview
13.1.5 Schott Latest Developments
13.2 Nippon Electric Glass
13.2.1 Nippon Electric Glass Company Information
13.2.2 Nippon Electric Glass Vaccine Vial Product Portfolios and Specifications
13.2.3 Nippon Electric Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nippon Electric Glass Main Business Overview
13.2.5 Nippon Electric Glass Latest Developments
13.3 Corning
13.3.1 Corning Company Information
13.3.2 Corning Vaccine Vial Product Portfolios and Specifications
13.3.3 Corning Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Corning Main Business Overview
13.3.5 Corning Latest Developments
13.4 DWK Life Sciences
13.4.1 DWK Life Sciences Company Information
13.4.2 DWK Life Sciences Vaccine Vial Product Portfolios and Specifications
13.4.3 DWK Life Sciences Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 DWK Life Sciences Main Business Overview
13.4.5 DWK Life Sciences Latest Developments
13.5 Richland Glass
13.5.1 Richland Glass Company Information
13.5.2 Richland Glass Vaccine Vial Product Portfolios and Specifications
13.5.3 Richland Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Richland Glass Main Business Overview
13.5.5 Richland Glass Latest Developments
13.6 Nipro
13.6.1 Nipro Company Information
13.6.2 Nipro Vaccine Vial Product Portfolios and Specifications
13.6.3 Nipro Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nipro Main Business Overview
13.6.5 Nipro Latest Developments
13.7 Pacific Vial Manufacturing
13.7.1 Pacific Vial Manufacturing Company Information
13.7.2 Pacific Vial Manufacturing Vaccine Vial Product Portfolios and Specifications
13.7.3 Pacific Vial Manufacturing Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pacific Vial Manufacturing Main Business Overview
13.7.5 Pacific Vial Manufacturing Latest Developments
13.8 Origin Ltd
13.8.1 Origin Ltd Company Information
13.8.2 Origin Ltd Vaccine Vial Product Portfolios and Specifications
13.8.3 Origin Ltd Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Origin Ltd Main Business Overview
13.8.5 Origin Ltd Latest Developments
13.9 Stevanato Group
13.9.1 Stevanato Group Company Information
13.9.2 Stevanato Group Vaccine Vial Product Portfolios and Specifications
13.9.3 Stevanato Group Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Stevanato Group Main Business Overview
13.9.5 Stevanato Group Latest Developments
13.10 SGD Pharma
13.10.1 SGD Pharma Company Information
13.10.2 SGD Pharma Vaccine Vial Product Portfolios and Specifications
13.10.3 SGD Pharma Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SGD Pharma Main Business Overview
13.10.5 SGD Pharma Latest Developments
13.11 Piramal Glass
13.11.1 Piramal Glass Company Information
13.11.2 Piramal Glass Vaccine Vial Product Portfolios and Specifications
13.11.3 Piramal Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Piramal Glass Main Business Overview
13.11.5 Piramal Glass Latest Developments
13.12 Zheng Chuan
13.12.1 Zheng Chuan Company Information
13.12.2 Zheng Chuan Vaccine Vial Product Portfolios and Specifications
13.12.3 Zheng Chuan Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zheng Chuan Main Business Overview
13.12.5 Zheng Chuan Latest Developments
13.13 Shandong Pharmaceutical Glass
13.13.1 Shandong Pharmaceutical Glass Company Information
13.13.2 Shandong Pharmaceutical Glass Vaccine Vial Product Portfolios and Specifications
13.13.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Pharmaceutical Glass Main Business Overview
13.13.5 Shandong Pharmaceutical Glass Latest Developments
13.14 Gerresheimer
13.14.1 Gerresheimer Company Information
13.14.2 Gerresheimer Vaccine Vial Product Portfolios and Specifications
13.14.3 Gerresheimer Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Gerresheimer Main Business Overview
13.14.5 Gerresheimer Latest Developments
13.15 Four Stars Glass
13.15.1 Four Stars Glass Company Information
13.15.2 Four Stars Glass Vaccine Vial Product Portfolios and Specifications
13.15.3 Four Stars Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Four Stars Glass Main Business Overview
13.15.5 Four Stars Glass Latest Developments
13.16 JOTOP Glass
13.16.1 JOTOP Glass Company Information
13.16.2 JOTOP Glass Vaccine Vial Product Portfolios and Specifications
13.16.3 JOTOP Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 JOTOP Glass Main Business Overview
13.16.5 JOTOP Glass Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Vial Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccine Vial by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccine Vial by Country/Region, 2018, 2022 & 2029
2.2 Vaccine Vial Segment by Type
2.2.1 Single Dose
2.2.2 Multi-dose
2.3 Vaccine Vial Sales by Type
2.3.1 Global Vaccine Vial Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccine Vial Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccine Vial Sale Price by Type (2018-2023)
2.4 Vaccine Vial Segment by Application
2.4.1 Preventive Vaccine
2.4.2 Therapeutic Vaccine
2.5 Vaccine Vial Sales by Application
2.5.1 Global Vaccine Vial Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccine Vial Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccine Vial Sale Price by Application (2018-2023)
3 GLOBAL VACCINE VIAL BY COMPANY
3.1 Global Vaccine Vial Breakdown Data by Company
3.1.1 Global Vaccine Vial Annual Sales by Company (2018-2023)
3.1.2 Global Vaccine Vial Sales Market Share by Company (2018-2023)
3.2 Global Vaccine Vial Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccine Vial Revenue by Company (2018-2023)
3.2.2 Global Vaccine Vial Revenue Market Share by Company (2018-2023)
3.3 Global Vaccine Vial Sale Price by Company
3.4 Key Manufacturers Vaccine Vial Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Vial Product Location Distribution
3.4.2 Players Vaccine Vial Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINE VIAL BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Vial Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccine Vial Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccine Vial Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccine Vial Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccine Vial Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccine Vial Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccine Vial Sales Growth
4.4 APAC Vaccine Vial Sales Growth
4.5 Europe Vaccine Vial Sales Growth
4.6 Middle East & Africa Vaccine Vial Sales Growth
5 AMERICAS
5.1 Americas Vaccine Vial Sales by Country
5.1.1 Americas Vaccine Vial Sales by Country (2018-2023)
5.1.2 Americas Vaccine Vial Revenue by Country (2018-2023)
5.2 Americas Vaccine Vial Sales by Type
5.3 Americas Vaccine Vial Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Vial Sales by Region
6.1.1 APAC Vaccine Vial Sales by Region (2018-2023)
6.1.2 APAC Vaccine Vial Revenue by Region (2018-2023)
6.2 APAC Vaccine Vial Sales by Type
6.3 APAC Vaccine Vial Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Vial by Country
7.1.1 Europe Vaccine Vial Sales by Country (2018-2023)
7.1.2 Europe Vaccine Vial Revenue by Country (2018-2023)
7.2 Europe Vaccine Vial Sales by Type
7.3 Europe Vaccine Vial Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Vial by Country
8.1.1 Middle East & Africa Vaccine Vial Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccine Vial Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccine Vial Sales by Type
8.3 Middle East & Africa Vaccine Vial Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Vial
10.3 Manufacturing Process Analysis of Vaccine Vial
10.4 Industry Chain Structure of Vaccine Vial
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Vial Distributors
11.3 Vaccine Vial Customer
12 WORLD FORECAST REVIEW FOR VACCINE VIAL BY GEOGRAPHIC REGION
12.1 Global Vaccine Vial Market Size Forecast by Region
12.1.1 Global Vaccine Vial Forecast by Region (2024-2029)
12.1.2 Global Vaccine Vial Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccine Vial Forecast by Type
12.7 Global Vaccine Vial Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Schott
13.1.1 Schott Company Information
13.1.2 Schott Vaccine Vial Product Portfolios and Specifications
13.1.3 Schott Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Schott Main Business Overview
13.1.5 Schott Latest Developments
13.2 Nippon Electric Glass
13.2.1 Nippon Electric Glass Company Information
13.2.2 Nippon Electric Glass Vaccine Vial Product Portfolios and Specifications
13.2.3 Nippon Electric Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nippon Electric Glass Main Business Overview
13.2.5 Nippon Electric Glass Latest Developments
13.3 Corning
13.3.1 Corning Company Information
13.3.2 Corning Vaccine Vial Product Portfolios and Specifications
13.3.3 Corning Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Corning Main Business Overview
13.3.5 Corning Latest Developments
13.4 DWK Life Sciences
13.4.1 DWK Life Sciences Company Information
13.4.2 DWK Life Sciences Vaccine Vial Product Portfolios and Specifications
13.4.3 DWK Life Sciences Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 DWK Life Sciences Main Business Overview
13.4.5 DWK Life Sciences Latest Developments
13.5 Richland Glass
13.5.1 Richland Glass Company Information
13.5.2 Richland Glass Vaccine Vial Product Portfolios and Specifications
13.5.3 Richland Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Richland Glass Main Business Overview
13.5.5 Richland Glass Latest Developments
13.6 Nipro
13.6.1 Nipro Company Information
13.6.2 Nipro Vaccine Vial Product Portfolios and Specifications
13.6.3 Nipro Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nipro Main Business Overview
13.6.5 Nipro Latest Developments
13.7 Pacific Vial Manufacturing
13.7.1 Pacific Vial Manufacturing Company Information
13.7.2 Pacific Vial Manufacturing Vaccine Vial Product Portfolios and Specifications
13.7.3 Pacific Vial Manufacturing Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pacific Vial Manufacturing Main Business Overview
13.7.5 Pacific Vial Manufacturing Latest Developments
13.8 Origin Ltd
13.8.1 Origin Ltd Company Information
13.8.2 Origin Ltd Vaccine Vial Product Portfolios and Specifications
13.8.3 Origin Ltd Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Origin Ltd Main Business Overview
13.8.5 Origin Ltd Latest Developments
13.9 Stevanato Group
13.9.1 Stevanato Group Company Information
13.9.2 Stevanato Group Vaccine Vial Product Portfolios and Specifications
13.9.3 Stevanato Group Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Stevanato Group Main Business Overview
13.9.5 Stevanato Group Latest Developments
13.10 SGD Pharma
13.10.1 SGD Pharma Company Information
13.10.2 SGD Pharma Vaccine Vial Product Portfolios and Specifications
13.10.3 SGD Pharma Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SGD Pharma Main Business Overview
13.10.5 SGD Pharma Latest Developments
13.11 Piramal Glass
13.11.1 Piramal Glass Company Information
13.11.2 Piramal Glass Vaccine Vial Product Portfolios and Specifications
13.11.3 Piramal Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Piramal Glass Main Business Overview
13.11.5 Piramal Glass Latest Developments
13.12 Zheng Chuan
13.12.1 Zheng Chuan Company Information
13.12.2 Zheng Chuan Vaccine Vial Product Portfolios and Specifications
13.12.3 Zheng Chuan Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zheng Chuan Main Business Overview
13.12.5 Zheng Chuan Latest Developments
13.13 Shandong Pharmaceutical Glass
13.13.1 Shandong Pharmaceutical Glass Company Information
13.13.2 Shandong Pharmaceutical Glass Vaccine Vial Product Portfolios and Specifications
13.13.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Pharmaceutical Glass Main Business Overview
13.13.5 Shandong Pharmaceutical Glass Latest Developments
13.14 Gerresheimer
13.14.1 Gerresheimer Company Information
13.14.2 Gerresheimer Vaccine Vial Product Portfolios and Specifications
13.14.3 Gerresheimer Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Gerresheimer Main Business Overview
13.14.5 Gerresheimer Latest Developments
13.15 Four Stars Glass
13.15.1 Four Stars Glass Company Information
13.15.2 Four Stars Glass Vaccine Vial Product Portfolios and Specifications
13.15.3 Four Stars Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Four Stars Glass Main Business Overview
13.15.5 Four Stars Glass Latest Developments
13.16 JOTOP Glass
13.16.1 JOTOP Glass Company Information
13.16.2 JOTOP Glass Vaccine Vial Product Portfolios and Specifications
13.16.3 JOTOP Glass Vaccine Vial Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 JOTOP Glass Main Business Overview
13.16.5 JOTOP Glass Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Vial Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccine Vial Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Dose
Table 4. Major Players of Multi-dose
Table 5. Global Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 6. Global Vaccine Vial Sales Market Share by Type (2018-2023)
Table 7. Global Vaccine Vial Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vaccine Vial Revenue Market Share by Type (2018-2023)
Table 9. Global Vaccine Vial Sale Price by Type (2018-2023) & (US$/K Units)
Table 10. Global Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 11. Global Vaccine Vial Sales Market Share by Application (2018-2023)
Table 12. Global Vaccine Vial Revenue by Application (2018-2023)
Table 13. Global Vaccine Vial Revenue Market Share by Application (2018-2023)
Table 14. Global Vaccine Vial Sale Price by Application (2018-2023) & (US$/K Units)
Table 15. Global Vaccine Vial Sales by Company (2018-2023) & (K Units)
Table 16. Global Vaccine Vial Sales Market Share by Company (2018-2023)
Table 17. Global Vaccine Vial Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vaccine Vial Revenue Market Share by Company (2018-2023)
Table 19. Global Vaccine Vial Sale Price by Company (2018-2023) & (US$/K Units)
Table 20. Key Manufacturers Vaccine Vial Producing Area Distribution and Sales Area
Table 21. Players Vaccine Vial Products Offered
Table 22. Vaccine Vial Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaccine Vial Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vaccine Vial Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vaccine Vial Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vaccine Vial Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vaccine Vial Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vaccine Vial Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vaccine Vial Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vaccine Vial Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vaccine Vial Sales Market Share by Country (2018-2023)
Table 35. Americas Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 37. Americas Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vaccine Vial Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vaccine Vial Sales Market Share by Region (2018-2023)
Table 41. APAC Vaccine Vial Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vaccine Vial Revenue Market Share by Region (2018-2023)
Table 43. APAC Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vaccine Vial Sales Market Share by Country (2018-2023)
Table 47. Europe Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 49. Europe Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vaccine Vial Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vaccine Vial
Table 58. Key Market Challenges & Risks of Vaccine Vial
Table 59. Key Industry Trends of Vaccine Vial
Table 60. Vaccine Vial Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vaccine Vial Distributors List
Table 63. Vaccine Vial Customer List
Table 64. Global Vaccine Vial Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vaccine Vial Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vaccine Vial Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vaccine Vial Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vaccine Vial Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vaccine Vial Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vaccine Vial Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vaccine Vial Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Schott Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 79. Schott Vaccine Vial Product Portfolios and Specifications
Table 80. Schott Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 81. Schott Main Business
Table 82. Schott Latest Developments
Table 83. Nippon Electric Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 84. Nippon Electric Glass Vaccine Vial Product Portfolios and Specifications
Table 85. Nippon Electric Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 86. Nippon Electric Glass Main Business
Table 87. Nippon Electric Glass Latest Developments
Table 88. Corning Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 89. Corning Vaccine Vial Product Portfolios and Specifications
Table 90. Corning Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 91. Corning Main Business
Table 92. Corning Latest Developments
Table 93. DWK Life Sciences Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 94. DWK Life Sciences Vaccine Vial Product Portfolios and Specifications
Table 95. DWK Life Sciences Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 96. DWK Life Sciences Main Business
Table 97. DWK Life Sciences Latest Developments
Table 98. Richland Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 99. Richland Glass Vaccine Vial Product Portfolios and Specifications
Table 100. Richland Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 101. Richland Glass Main Business
Table 102. Richland Glass Latest Developments
Table 103. Nipro Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 104. Nipro Vaccine Vial Product Portfolios and Specifications
Table 105. Nipro Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 106. Nipro Main Business
Table 107. Nipro Latest Developments
Table 108. Pacific Vial Manufacturing Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 109. Pacific Vial Manufacturing Vaccine Vial Product Portfolios and Specifications
Table 110. Pacific Vial Manufacturing Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 111. Pacific Vial Manufacturing Main Business
Table 112. Pacific Vial Manufacturing Latest Developments
Table 113. Origin Ltd Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 114. Origin Ltd Vaccine Vial Product Portfolios and Specifications
Table 115. Origin Ltd Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 116. Origin Ltd Main Business
Table 117. Origin Ltd Latest Developments
Table 118. Stevanato Group Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 119. Stevanato Group Vaccine Vial Product Portfolios and Specifications
Table 120. Stevanato Group Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 121. Stevanato Group Main Business
Table 122. Stevanato Group Latest Developments
Table 123. SGD Pharma Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 124. SGD Pharma Vaccine Vial Product Portfolios and Specifications
Table 125. SGD Pharma Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 126. SGD Pharma Main Business
Table 127. SGD Pharma Latest Developments
Table 128. Piramal Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 129. Piramal Glass Vaccine Vial Product Portfolios and Specifications
Table 130. Piramal Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 131. Piramal Glass Main Business
Table 132. Piramal Glass Latest Developments
Table 133. Zheng Chuan Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 134. Zheng Chuan Vaccine Vial Product Portfolios and Specifications
Table 135. Zheng Chuan Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 136. Zheng Chuan Main Business
Table 137. Zheng Chuan Latest Developments
Table 138. Shandong Pharmaceutical Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Pharmaceutical Glass Vaccine Vial Product Portfolios and Specifications
Table 140. Shandong Pharmaceutical Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 141. Shandong Pharmaceutical Glass Main Business
Table 142. Shandong Pharmaceutical Glass Latest Developments
Table 143. Gerresheimer Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 144. Gerresheimer Vaccine Vial Product Portfolios and Specifications
Table 145. Gerresheimer Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 146. Gerresheimer Main Business
Table 147. Gerresheimer Latest Developments
Table 148. Four Stars Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 149. Four Stars Glass Vaccine Vial Product Portfolios and Specifications
Table 150. Four Stars Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 151. Four Stars Glass Main Business
Table 152. Four Stars Glass Latest Developments
Table 153. JOTOP Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 154. JOTOP Glass Vaccine Vial Product Portfolios and Specifications
Table 155. JOTOP Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 156. JOTOP Glass Main Business
Table 157. JOTOP Glass Latest Developments
Table 1. Vaccine Vial Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccine Vial Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Dose
Table 4. Major Players of Multi-dose
Table 5. Global Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 6. Global Vaccine Vial Sales Market Share by Type (2018-2023)
Table 7. Global Vaccine Vial Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vaccine Vial Revenue Market Share by Type (2018-2023)
Table 9. Global Vaccine Vial Sale Price by Type (2018-2023) & (US$/K Units)
Table 10. Global Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 11. Global Vaccine Vial Sales Market Share by Application (2018-2023)
Table 12. Global Vaccine Vial Revenue by Application (2018-2023)
Table 13. Global Vaccine Vial Revenue Market Share by Application (2018-2023)
Table 14. Global Vaccine Vial Sale Price by Application (2018-2023) & (US$/K Units)
Table 15. Global Vaccine Vial Sales by Company (2018-2023) & (K Units)
Table 16. Global Vaccine Vial Sales Market Share by Company (2018-2023)
Table 17. Global Vaccine Vial Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vaccine Vial Revenue Market Share by Company (2018-2023)
Table 19. Global Vaccine Vial Sale Price by Company (2018-2023) & (US$/K Units)
Table 20. Key Manufacturers Vaccine Vial Producing Area Distribution and Sales Area
Table 21. Players Vaccine Vial Products Offered
Table 22. Vaccine Vial Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaccine Vial Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vaccine Vial Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vaccine Vial Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vaccine Vial Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vaccine Vial Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vaccine Vial Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vaccine Vial Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vaccine Vial Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vaccine Vial Sales Market Share by Country (2018-2023)
Table 35. Americas Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 37. Americas Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vaccine Vial Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vaccine Vial Sales Market Share by Region (2018-2023)
Table 41. APAC Vaccine Vial Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vaccine Vial Revenue Market Share by Region (2018-2023)
Table 43. APAC Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vaccine Vial Sales Market Share by Country (2018-2023)
Table 47. Europe Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 49. Europe Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vaccine Vial Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vaccine Vial Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vaccine Vial Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vaccine Vial Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccine Vial Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vaccine Vial Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vaccine Vial
Table 58. Key Market Challenges & Risks of Vaccine Vial
Table 59. Key Industry Trends of Vaccine Vial
Table 60. Vaccine Vial Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vaccine Vial Distributors List
Table 63. Vaccine Vial Customer List
Table 64. Global Vaccine Vial Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vaccine Vial Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vaccine Vial Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vaccine Vial Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vaccine Vial Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vaccine Vial Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vaccine Vial Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vaccine Vial Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vaccine Vial Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vaccine Vial Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Schott Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 79. Schott Vaccine Vial Product Portfolios and Specifications
Table 80. Schott Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 81. Schott Main Business
Table 82. Schott Latest Developments
Table 83. Nippon Electric Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 84. Nippon Electric Glass Vaccine Vial Product Portfolios and Specifications
Table 85. Nippon Electric Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 86. Nippon Electric Glass Main Business
Table 87. Nippon Electric Glass Latest Developments
Table 88. Corning Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 89. Corning Vaccine Vial Product Portfolios and Specifications
Table 90. Corning Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 91. Corning Main Business
Table 92. Corning Latest Developments
Table 93. DWK Life Sciences Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 94. DWK Life Sciences Vaccine Vial Product Portfolios and Specifications
Table 95. DWK Life Sciences Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 96. DWK Life Sciences Main Business
Table 97. DWK Life Sciences Latest Developments
Table 98. Richland Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 99. Richland Glass Vaccine Vial Product Portfolios and Specifications
Table 100. Richland Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 101. Richland Glass Main Business
Table 102. Richland Glass Latest Developments
Table 103. Nipro Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 104. Nipro Vaccine Vial Product Portfolios and Specifications
Table 105. Nipro Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 106. Nipro Main Business
Table 107. Nipro Latest Developments
Table 108. Pacific Vial Manufacturing Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 109. Pacific Vial Manufacturing Vaccine Vial Product Portfolios and Specifications
Table 110. Pacific Vial Manufacturing Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 111. Pacific Vial Manufacturing Main Business
Table 112. Pacific Vial Manufacturing Latest Developments
Table 113. Origin Ltd Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 114. Origin Ltd Vaccine Vial Product Portfolios and Specifications
Table 115. Origin Ltd Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 116. Origin Ltd Main Business
Table 117. Origin Ltd Latest Developments
Table 118. Stevanato Group Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 119. Stevanato Group Vaccine Vial Product Portfolios and Specifications
Table 120. Stevanato Group Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 121. Stevanato Group Main Business
Table 122. Stevanato Group Latest Developments
Table 123. SGD Pharma Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 124. SGD Pharma Vaccine Vial Product Portfolios and Specifications
Table 125. SGD Pharma Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 126. SGD Pharma Main Business
Table 127. SGD Pharma Latest Developments
Table 128. Piramal Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 129. Piramal Glass Vaccine Vial Product Portfolios and Specifications
Table 130. Piramal Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 131. Piramal Glass Main Business
Table 132. Piramal Glass Latest Developments
Table 133. Zheng Chuan Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 134. Zheng Chuan Vaccine Vial Product Portfolios and Specifications
Table 135. Zheng Chuan Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 136. Zheng Chuan Main Business
Table 137. Zheng Chuan Latest Developments
Table 138. Shandong Pharmaceutical Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Pharmaceutical Glass Vaccine Vial Product Portfolios and Specifications
Table 140. Shandong Pharmaceutical Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 141. Shandong Pharmaceutical Glass Main Business
Table 142. Shandong Pharmaceutical Glass Latest Developments
Table 143. Gerresheimer Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 144. Gerresheimer Vaccine Vial Product Portfolios and Specifications
Table 145. Gerresheimer Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 146. Gerresheimer Main Business
Table 147. Gerresheimer Latest Developments
Table 148. Four Stars Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 149. Four Stars Glass Vaccine Vial Product Portfolios and Specifications
Table 150. Four Stars Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 151. Four Stars Glass Main Business
Table 152. Four Stars Glass Latest Developments
Table 153. JOTOP Glass Basic Information, Vaccine Vial Manufacturing Base, Sales Area and Its Competitors
Table 154. JOTOP Glass Vaccine Vial Product Portfolios and Specifications
Table 155. JOTOP Glass Vaccine Vial Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 156. JOTOP Glass Main Business
Table 157. JOTOP Glass Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine Vial
Figure 2. Vaccine Vial Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Vial Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vaccine Vial Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccine Vial Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Dose
Figure 10. Product Picture of Multi-dose
Figure 11. Global Vaccine Vial Sales Market Share by Type in 2022
Figure 12. Global Vaccine Vial Revenue Market Share by Type (2018-2023)
Figure 13. Vaccine Vial Consumed in Preventive Vaccine
Figure 14. Global Vaccine Vial Market: Preventive Vaccine (2018-2023) & (K Units)
Figure 15. Vaccine Vial Consumed in Therapeutic Vaccine
Figure 16. Global Vaccine Vial Market: Therapeutic Vaccine (2018-2023) & (K Units)
Figure 17. Global Vaccine Vial Sales Market Share by Application (2022)
Figure 18. Global Vaccine Vial Revenue Market Share by Application in 2022
Figure 19. Vaccine Vial Sales Market by Company in 2022 (K Units)
Figure 20. Global Vaccine Vial Sales Market Share by Company in 2022
Figure 21. Vaccine Vial Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vaccine Vial Revenue Market Share by Company in 2022
Figure 23. Global Vaccine Vial Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vaccine Vial Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vaccine Vial Sales 2018-2023 (K Units)
Figure 26. Americas Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vaccine Vial Sales 2018-2023 (K Units)
Figure 28. APAC Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vaccine Vial Sales 2018-2023 (K Units)
Figure 30. Europe Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vaccine Vial Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vaccine Vial Sales Market Share by Country in 2022
Figure 34. Americas Vaccine Vial Revenue Market Share by Country in 2022
Figure 35. Americas Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 36. Americas Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 37. United States Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vaccine Vial Sales Market Share by Region in 2022
Figure 42. APAC Vaccine Vial Revenue Market Share by Regions in 2022
Figure 43. APAC Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 44. APAC Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 45. China Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vaccine Vial Sales Market Share by Country in 2022
Figure 53. Europe Vaccine Vial Revenue Market Share by Country in 2022
Figure 54. Europe Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 55. Europe Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 56. Germany Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vaccine Vial Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vaccine Vial Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vaccine Vial in 2022
Figure 71. Manufacturing Process Analysis of Vaccine Vial
Figure 72. Industry Chain Structure of Vaccine Vial
Figure 73. Channels of Distribution
Figure 74. Global Vaccine Vial Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vaccine Vial Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vaccine Vial Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vaccine Vial Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vaccine Vial Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vaccine Vial Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Vaccine Vial
Figure 2. Vaccine Vial Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Vial Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vaccine Vial Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccine Vial Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Dose
Figure 10. Product Picture of Multi-dose
Figure 11. Global Vaccine Vial Sales Market Share by Type in 2022
Figure 12. Global Vaccine Vial Revenue Market Share by Type (2018-2023)
Figure 13. Vaccine Vial Consumed in Preventive Vaccine
Figure 14. Global Vaccine Vial Market: Preventive Vaccine (2018-2023) & (K Units)
Figure 15. Vaccine Vial Consumed in Therapeutic Vaccine
Figure 16. Global Vaccine Vial Market: Therapeutic Vaccine (2018-2023) & (K Units)
Figure 17. Global Vaccine Vial Sales Market Share by Application (2022)
Figure 18. Global Vaccine Vial Revenue Market Share by Application in 2022
Figure 19. Vaccine Vial Sales Market by Company in 2022 (K Units)
Figure 20. Global Vaccine Vial Sales Market Share by Company in 2022
Figure 21. Vaccine Vial Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vaccine Vial Revenue Market Share by Company in 2022
Figure 23. Global Vaccine Vial Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vaccine Vial Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vaccine Vial Sales 2018-2023 (K Units)
Figure 26. Americas Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vaccine Vial Sales 2018-2023 (K Units)
Figure 28. APAC Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vaccine Vial Sales 2018-2023 (K Units)
Figure 30. Europe Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vaccine Vial Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Vaccine Vial Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vaccine Vial Sales Market Share by Country in 2022
Figure 34. Americas Vaccine Vial Revenue Market Share by Country in 2022
Figure 35. Americas Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 36. Americas Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 37. United States Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vaccine Vial Sales Market Share by Region in 2022
Figure 42. APAC Vaccine Vial Revenue Market Share by Regions in 2022
Figure 43. APAC Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 44. APAC Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 45. China Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vaccine Vial Sales Market Share by Country in 2022
Figure 53. Europe Vaccine Vial Revenue Market Share by Country in 2022
Figure 54. Europe Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 55. Europe Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 56. Germany Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vaccine Vial Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vaccine Vial Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vaccine Vial Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vaccine Vial Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vaccine Vial Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vaccine Vial in 2022
Figure 71. Manufacturing Process Analysis of Vaccine Vial
Figure 72. Industry Chain Structure of Vaccine Vial
Figure 73. Channels of Distribution
Figure 74. Global Vaccine Vial Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vaccine Vial Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vaccine Vial Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vaccine Vial Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vaccine Vial Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vaccine Vial Revenue Market Share Forecast by Application (2024-2029)
